Table of Content

Executive Summary

1 Market Overview
1.1 Market Definition
1.2 Precision Medicine: A Frontier in the Genesis of Patient-Centric Medicine
1.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
1.4 Initiatives and Programs
1.5 Precision Medicine: Enabling Technologies and Applications
1.5.1 Innovators
1.5.1.1 3D DNA Printing
1.5.1.1.1 Introduction
1.5.1.1.2 Role of 3D DNA Printing
1.5.1.2 RNA-Seq
1.5.1.2.1 Introduction
1.5.1.2.2 Role of RNA-Seq in Precision Medicine
1.5.1.2.3 Key Players
1.5.1.3 4D Molecular Imaging
1.5.1.3.1 Introduction
1.5.1.3.2 Role of 4D Molecular Imaging in Precision Medicine
1.5.1.3.3 Key Players
1.5.2 Early Adopters
1.5.2.1 CRISPR
1.5.2.1.1 Introduction
1.5.2.1.2 Role of CRISPR in Precision Medicine
1.5.2.1.3 Key Players
1.5.2.2 Blockchain
1.5.2.2.1 Introduction
1.5.2.2.2 Role of Blockchain in Precision Medicine
1.5.2.2.3 Key Players
1.5.2.3 Imaging Informatics
1.5.2.3.1 Introduction
1.5.2.3.2 Role of Imaging Informatics in Precision Medicine
1.5.2.3.3 Key Players
1.5.3 Early Majority
1.5.3.1 Artificial Intelligence (AI)
1.5.3.1.1 Introduction
1.5.3.1.2 Role of Artificial Intelligence in Precision Medicine
1.5.3.1.3 Key Players
1.5.3.2 Circulating Free DNA (cfDNA)
1.5.3.2.1 Introduction
1.5.3.2.2 Role of cfDNA in Precision Medicine
1.5.3.2.3 Key Players
1.5.3.3 Big Data
1.5.3.3.1 Introduction
1.5.3.3.2 Role of Big Data in Precision Medicine
1.5.3.3.3 Key Players
1.5.3.4 Next-Generation Sequencing (NGS)
1.5.3.4.1 Introduction
1.5.3.4.2 Role of NGS in Precision Medicine
1.5.3.4.3 Key Players
1.5.3.5 Health Informatics
1.5.3.5.1 Introduction
1.5.3.5.2 Role of Health Informatics in Precision Medicine
1.5.3.5.3 Key players
1.5.3.6 Bioinformatics
1.5.3.6.1 Introduction
1.5.3.6.2 Role of Bioinformatics in Precision Medicine
1.5.3.6.3 Key Players
1.5.4 Late Majority
1.5.4.1 Polymerase Chain Reactions (PCR)
1.5.4.1.1 Introduction
1.5.4.1.2 Role of PCR in Precision Medicine
1.5.4.1.3 Key players
1.5.4.2 Microarray
1.5.4.2.1 Role of Microarray in Precision Medicine
1.5.4.2.2 Key Players

2 Market: Industry Outlook
2.1 Global Precision Medicine Market: Ecosystem Analysis
2.2 Market Trends
2.2.1 Integrating Advanced Imaging for Enhanced Diagnostics and Treatment
2.2.2 Emergence of Biobanks as a Cornerstone of Precision Medicine
2.3 Market Dynamics Overview
2.3.1 Market Drivers
2.3.1.1 Advancement of Sequencing Technologies
2.3.1.2 Rising Prevalence of Chronic Disease across the Globe
2.3.1.3 Potential to Reduce Healthcare Costs across the Globe
2.3.1.4 Potential to Reduce Adverse Drug Reaction through Pharmacogenomic Testing
2.3.2 Market Restraints
2.3.2.1 Data Integration and Interoperability Issues
2.3.2.2 High Costs and Limited Accessibility
2.3.2.3 Limited Reimbursement and Insurance Coverage
2.3.3 Market Opportunities
2.3.3.1 AI Integration in Precision Medicine
2.3.3.2 Increasing Collaborations and Partnerships
2.4 Industry Insights
2.4.1 Patent Analysis
2.4.2 Pipeline Analysis
2.4.3 Legal Requirements and Regulations
2.4.4 Legal Requirements and Framework by FDA
2.4.5 Legal Requirements and Framework by the EMA
2.4.6 Legal Requirements and Framework by the MHLW
2.5 Ecosystem Summary
2.6 Market Overview
2.7 Applied Sciences
2.7.1 Genomics
2.7.2 Global Precision Medicine Market (by Applied Science) (by Genomics)
2.7.2.1 Polymerase Chain Reaction (PCR)
2.7.2.1.1 Global Precision Medicine PCR Market (by Product)
2.7.2.1.2 Global Precision Medicine PCR Market (by End User)
2.7.2.1.3 Global Precision Medicine PCR Market (by Region)
2.7.2.2 Next-Generation Sequencing (NGS)
2.7.2.2.1 Global Precision Medicine NGS Market (by Product)
2.7.2.2.2 Global Precision Medicine NGS Market (by Technology)
2.7.2.2.3 Global Precision Medicine NGS Market (by End User)
2.7.2.2.4 Global Precision Medicine NGS Market (by Region)
2.7.2.3 Genome Editing
2.7.2.3.1 Global Precision Medicine Genome Editing Market (by Product)
2.7.2.3.2 Global Precision Medicine Genome Editing Market (by End User)
2.7.2.3.3 Global Precision Medicine Genome Editing Market (by Region)
2.7.2.4 Other Technologies
2.7.2.4.1 Global Precision Medicine Other Technologies Market (by Region)
2.7.3 Pharmacogenomics
2.7.3.1 Global Precision Medicine Pharmacogenomics Market (by Pharmacogenomics Services)
2.7.3.2 Global Precision Medicine Pharmacogenomics Market (by End User)
2.7.3.3 Global Precision Medicine Pharmacogenomics Market (by Region)
2.7.4 Other Applied Sciences
2.8 Precision Diagnostics
2.8.1 Molecular Diagnostics (MDx)
2.8.2 Global Precision Medicine Market (by Molecular Diagnostics (by Type)
2.8.2.1 Non-Invasive Prenatal Testing (NIPT)
2.8.2.1.1 Global Precision Medicine NIPT Market (by Platform)
2.8.2.1.2 Global Precision Medicine NIPT Market (by Region)
2.8.2.2 Companion Diagnostics
2.8.2.2.1 Global Precision Medicine Companion Diagnostics Market (by Technology)
2.8.2.2.2 Global Precision Medicine Companion Diagnostics Market (by Indication)
2.8.2.2.3 Global Precision Medicine Companion Diagnostics Market (by Region)
2.8.2.3 Liquid Biopsy
2.8.2.3.1 Global Precision Medicine Liquid Biopsy Market (by Indication)
2.8.2.3.2 Global Precision Medicine Liquid Biopsy Market (by Region)
2.8.2.4 Other Molecular Diagnostics
2.8.2.4.1 Global Precision Medicine Other Molecular Diagnostics Market (by Type)
2.8.2.4.2 Global Precision Medicine Other Molecular Diagnostics Market (by Region)
2.8.3 Medical Imaging
2.8.3.1 Global Precision Medicine Market (by Precision Diagnostics) (by Medical Imaging) (by Type)
2.8.3.1.1 Imaging Analytics
2.8.3.1.2 Imaging Computer-Aided Detection (CADx)
2.8.3.2 Global Precision Medicine Market (by Precision Diagnostics) (by Medical Imaging) (by Region)
2.9 Digital Health and Information Technology
2.9.1 Global Precision Medicine Market (by Digital Health and Information Technology) (by Type)
2.9.1.1 Clinical Decision Support Systems (CDSS)
2.9.1.2 Big Data Analytics
2.9.1.3 IT Infrastructure
2.9.1.3.1 Global Precision Medicine Market (by Digital Health and Information Technology) (by IT Infrastructure) (by Type)
2.9.1.4 Genomics Informatics
2.9.1.4.1 Global Precision Medicine Market (by Digital Health and Information Technology) (by Genomics Informatics) (by Product Type)
2.9.1.5 In-Silico Informatics
2.9.1.6 Mobile Health
2.9.2 Global Precision Medicine Market (by Digital Health and Information Technology) (by End User)
2.9.3 Global Precision Medicine Market (by Digital Health and Information Technology ) (by Region)
2.1 Precision Therapeutics
2.10.1 Global Precision Medicine Market (by Precision Therapeutics)
2.10.1.1 Clinical Trials
2.10.1.1.1 Global Precision Medicine Market (by Precision Therapeutics) (by Clinical Trials) (by Region)
2.10.1.2 Cell Therapy
2.10.1.2.1 Global Precision Medicine Market (by Precision Therapeutics) (by Cell Therapy) (by Region)
2.10.1.3 Drug Discovery and Research
2.10.1.3.1 Global Precision Medicine Market (by Precision Therapeutics) (by Drug Discovery and Research) (by Region)
2.10.1.4 Gene Therapy
2.10.1.4.1 Global Precision Medicine Market (by Precision Therapeutics) (by Gene Therapy) (by Region)

3 Application
3.1 Application Summary
3.2 Overview
3.3 Oncology
3.3.1 Global Precision Medicine Market (by Oncology)
3.4 Infectious Diseases
3.4.1 Global Precision Medicine Market (by Infectious Disease)
3.5 Neurology
3.5.1 Global Precision Medicine Market (by Neurology)
3.6 Cardiovascular
3.6.1 Global Precision Medicine Market (by Cardiovascular Disease)
3.7 Lifestyle and Endocrinology
3.7.1 Global Precision Medicine Market (by Lifesctyle and Endocrinology)
3.8 Gastroenterology
3.8.1 Global Precision Medicine Market (by Gastroenterology)
3.9 Other Applications
3.9.1 Global Precision Medicine Market (by Other Application)

4 Region
4.1 Overview
4.2 North America
4.2.1 Regional Overview
4.2.2 Driving Factors for Market Growth
4.2.3 Factors Challenging the Market
4.2.3.1 Ecosystem
4.2.4 U.S.
4.2.4.1 U.S. Precision Medicine Market (by Ecosystem),
4.2.5 Canada
4.2.5.1 Canada Precision Medicine Market (by Ecosystem)
4.3 Europe
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.3.1 Europe Precision Medicine Market (by Ecosystem),
4.3.4 Germany
4.3.4.1 Germany Precision Medicine Market (by Ecosystem),
4.3.5 France
4.3.5.1 France Precision Medicine Market (by Ecosystem)
4.3.6 Italy
4.3.6.1 Italy Precision Medicine Market (by Ecosystem),
4.3.7 U.K.
4.3.7.1 U.K. Precision Medicine Market (by Ecosystem),
4.3.8 Spain
4.3.8.1 Spain. Precision Medicine Market (by Ecosystem),
4.3.9 Rest-of-Europe
4.3.9.1 Rest-of-Europe Precision Medicine Market (by Ecosystem)
4.4 Asia-Pacific
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.3.1 Asia-Pacific Precision Medicine Market (by Ecosystem)
4.4.4 Japan
4.4.4.1 Japan Precision Medicine Market (by Ecosystem
4.4.5 China
4.4.5.1 China Precision Medicine Market (by Ecosystem),
4.4.6 India
4.4.6.1 India Precision Medicine Market (by Ecosystem),
4.4.7 Australia
4.4.7.1 Australia Precision Medicine Market (by Ecosystem),
4.4.8 South Korea
4.4.8.1 South Korea. Precision Medicine Market (by Ecosystem)
4.4.9 Rest-of-APAC
4.4.9.1 Rest-of-APAC Precision Medicine Market (by Ecosystem)
4.5 Latin America
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.3.1 Latin America Precision Medicine Market (by Ecosystem)
4.5.4 Brazil
4.5.4.1 Brazil Precision Medicine Market (by Ecosystem)
4.5.5 Mexico
4.5.5.1 Mexico Precision Medicine Market (by Ecosystem),
4.5.6 Rest-of-Latin America
4.5.6.1 Rest-of-Latin America Precision Medicine Market (by Ecosystem),
4.6 MEA
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.3.1 Middle East and Africa Precision Medicine Market (by Ecosystem),
4.6.4 K.S.A
4.6.4.1 K.S.A Precision Medicine Market (by Ecosystem),
4.6.5 South Africa
4.6.5.1 South Africa Precision Medicine Market (by Ecosystem)
4.6.6 Rest-of-MEA
4.6.6.1 Rest of MEA Precision Medicine Market (by Ecosystem)

5 Competitive Landscape
5.1 Competitive Landscape
5.1.1 Synergistic Activities
5.2 Company Profiles
5.2.1 Abbott
5.2.1.1 Overview
5.2.1.2 Top Products
5.2.1.3 Top Competitors
5.2.1.4 Analyst View
5.2.2 Thermo Fisher Scientific, Inc.
5.2.2.1 Overview
5.2.2.2 Top Products
5.2.2.3 Top Competitors
5.2.2.4 Analyst View
5.2.3 Almac Group
5.2.3.1 Overview
5.2.3.2 Top Products/Services
5.2.3.3 Top Competitors
5.2.3.4 Analyst View
5.2.4 ANGLE plc
5.2.4.1 Overview
5.2.4.2 Top Products
5.2.4.3 Top Competitors
5.2.4.4 Analyst View
5.2.5 Astellas Pharma Inc
5.2.5.1 Overview
5.2.5.2 Top Products
5.2.5.3 Top Competitors
5.2.5.4 Analyst View
5.2.6 Bio-Rad Laboratories, Inc.
5.2.6.1 Overview
5.2.6.2 Top Products
5.2.6.3 Top Competitors
5.2.6.4 Analyst View
5.2.7 Epic Sciences
5.2.7.1 Overview
5.2.7.2 Top Products
5.2.7.3 Top Competitors
5.2.7.4 Analyst View
5.2.8 F. Hoffmann-La Roche Ltd.
5.2.8.1 Overview
5.2.8.2 Top Products
5.2.8.3 Top Competitors
5.2.8.4 Analyst View
5.2.9 Merck KGaA
5.2.9.1 Overview
5.2.9.2 Top Products
5.2.9.3 Top Competitors
5.2.9.4 Analyst View
5.2.10 Illumina, Inc.
5.2.10.1 Overview
5.2.10.2 Top Products
5.2.10.3 Top Competitors
5.2.10.4 Analyst View
5.2.11 QIAGEN N.V.
5.2.11.1 Overview
5.2.11.2 Top Products
5.2.11.3 Top Competitors
5.2.11.4 Analyst View
5.2.12 Sysmex Corporation
5.2.12.1 Overview
5.2.12.2 Top Products
5.2.12.3 Top Competitors
5.2.12.4 Analyst View
5.2.13 Laboratory Corporation of America Holdings
5.2.13.1 Overview
5.2.13.2 Top Products
5.2.13.3 Top Competitors
5.2.13.4 Analyst View
5.2.14 Danaher Corporation
5.2.14.1 Overview
5.2.14.2 Top Products/ Services
5.2.14.3 Top Competitors
5.2.14.4 Analyst View
5.2.15 Quest Diagnostics
5.2.15.1 Overview
5.2.15.2 Top Products
5.2.15.3 Top Competitors
5.2.15.4 Analyst View
5.2.16 AstraZeneca
5.2.16.1 Overview
5.2.16.2 Top Products
5.2.16.3 Top Competitors
5.2.16.4 Analyst View
5.2.17 ASURAGEN, INC
5.2.17.1 Overview
5.2.17.2 Top Products
5.2.17.3 Top Competitors
5.2.17.4 Analyst View
5.2.18 bioMérieux SA
5.2.18.1 Overview
5.2.18.2 Top Products
5.2.18.3 Top Competitors
5.2.18.4 Analyst View
5.2.19 Bristol-Myers Squibb
5.2.19.1 Overview
5.2.19.2 Top Products
5.2.19.3 Top Competitors
5.2.19.4 Analyst View
5.2.20 Pacific Biosciences of California, Inc.
5.2.20.1 Overview
5.2.20.2 Top Products
5.2.20.3 Top Competitors
5.2.20.4 Analyst View
5.2.21 Myriad Genetics, Inc.
5.2.21.1 Overview
5.2.21.2 Top Products
5.2.21.3 Top Competitors
5.2.21.4 Analyst View
5.2.22 Teva Pharmaceuticals Industries Ltd.
5.2.22.1 Overview
5.2.22.2 Top Products
5.2.22.3 Top Competitors
5.2.22.4 Analyst View
5.2.23 Sanofi S.A.
5.2.23.1 Overview
5.2.23.2 Top Products
5.2.23.3 Top Competitors
5.2.23.4 Analyst View
5.2.24 Randox Laboratories Ltd.
5.2.24.1 Overview
5.2.24.2 Top Products
5.2.24.3 Top Competitors
5.2.24.4 Analyst View
5.2.25 Eli Lilly and Company
5.2.25.1 Overview
5.2.25.2 Top Products
5.2.25.3 Top Competitors
5.2.25.4 Analyst View
5.2.26 Pfizer Inc.
5.2.26.1 Overview
5.2.26.2 Top Products
5.2.26.3 Top Competitors
5.2.26.4 Analyst View
5.2.27 Konica Minolta, Inc.
5.2.27.1 Overview
5.2.27.2 Top Products/Product Portfolio
5.2.27.3 Top Competitors
5.2.27.4 Analyst View
5.2.28 Cardiff Oncology
5.2.28.1 Overview
5.2.28.2 Top Products
5.2.28.3 Top Competitors
5.2.28.4 Analyst View
5.2.29 GE HealthCare
5.2.29.1 Overview
5.2.29.2 Top Products
5.2.29.3 Top Competitors
5.2.29.4 Analyst View
5.2.30 Gilead Science, Inc.
5.2.30.1 Overview
5.2.30.2 Top Products
5.2.30.3 Top Competitors
5.2.30.4 Analyst View
5.2.31 GSK plc
5.2.31.1 Overview
5.2.31.2 Top Products
5.2.31.3 Top Competitors
5.2.31.4 Analyst View
5.2.32 Johnson & Johnson
5.2.32.1 Overview
5.2.32.2 Top Products
5.2.32.3 Top Competitors
5.2.32.4 Analyst View
5.2.33 MDx Health, Inc.
5.2.33.1 Overview
5.2.33.2 Top Products
5.2.33.3 Top Competitors
5.2.33.4 Analyst View
5.2.34 Novartis AG
5.2.34.1 Overview
5.2.34.2 Top Products
5.2.34.3 Top Competitors
5.2.34.4 Analyst View
5.2.35 Oracle Corporation
5.2.35.1 Overview
5.2.35.2 Top Products
5.2.35.3 Top Competitors
5.2.35.4 Analyst View
5.2.36 Menarini Silicon Biosystems
5.2.36.1 Overview
5.2.36.2 Top Products
5.2.36.3 Top Competitors
5.2.36.4 Analyst View

6 Research Methodology
6.1 Global Precision Medicine Market: Research Methodology
6.1.1 Data Sources
6.1.1.1 Primary Data Sources
6.1.1.2 Secondary Data Sources
6.1.2 Data Triangulation
6.2 Market Estimation and Forecast

List of Figures
Figure 1: Global Precision Medicine Market, $Billion, 2023, 2028, and 2034
Figure 2: Precision Medicine: Treatment Tailored to an Individual’s Genetic Structure
Figure 3: Precision Medicine - a Multi-Faceted Approach to Patient Care
Figure 4: Decreasing Cost ($) and Increasing Output (TB) of Genome Sequencing, 2009-2025
Figure 5: Global Precision Medicine Market (by Region), $Billion, 2023, 2028, and 2034
Figure 6: Global Precision Medicine Market (by Ecosystem), $Billion, 2023, 2028, and 2034
Figure 7: Global Precision Medicine Market (by Application), $Million, 2023, 2028, and 2034
Figure 8: Precision Medicine Approach
Figure 9: Evolution of Precision Medicine Technology
Figure 10: Precision Medicine: Enabling Technologies and Applications
Figure 11: Structured Big Data Reporting Benefits
Figure 12: Generalized Process for the Microarray
Figure 13: Stakeholders in Precision Medicine
Figure 14: Impact Analysis of Global Precision Medicine Market Factors, 2024-2034
Figure 15: Evolution of DNA Sequencing Technologies
Figure 16: Cost of Sequencing a Full Human Genome, 2001-2022
Figure 17: Prevalence of Cancer, in Millions, 2022 - 2035
Figure 18: Global Burden of Chronic Disease
Figure 19: Role of AI in Precision Medicine
Figure 20: Number of Patents Files, 2020-2024
Figure 21: Precision Medicine by Top Patent Owner
Figure 22: Precision Medicine: The Ecosystem
Figure 23: Global Precision Medicine Market (by Applied Sciences)
Figure 24: Global Precision Medicine Market (by Applied Sciences), $Billion, 2023-2034
Figure 25: Precision Medicine: Multi-omics Sciences
Figure 26: Precision Medicine: Genomics
Figure 27: Global Precision Medicine Market (by Applied Science) (Genomics) $Billion, 2023-2034
Figure 28: Global Precision Medicine PCR Market, $Billion, 2023-2034
Figure 29: Global Precision Medicine PCR Market (by Product) $Billion, 2023-2034
Figure 30: Global Precision Medicine PCR Market (by End User) $Billion, 2023-2034
Figure 31: Global Precision Medicine PCR Market (by Region) $Billion, 2023-2034
Figure 32: Evolution of Next-Generation Sequencing
Figure 33: Global Precision Medicine NGS Market, $Billion, 2023-2034
Figure 34: Global Precision Medicine NGS Market (by Product), $Billion, 2023-2034
Figure 35: Global Precision Medicine NGS Market (by Technology), $Billion, 2023-2034
Figure 36: Global Precision Medicine NGS Market (by End User), $Billion, 2023-2034
Figure 37: Global Precision Medicine NGS Market (by Region), $Billion, 2023-2034
Figure 38: Global Precision Medicine Genome Editing Market, $Billion, 2023-2034
Figure 39: Global Precision Medicine Genome Editing Market (by Product), $Billion, 2023-2034
Figure 40: Global Precision Medicine Genome Editing Market (by End User), $Billion, 2023-2034
Figure 41: Global Precision Medicine Genome Editing Market (by Region), $Billion, 2023-2034
Figure 42: Global Precision Medicine Other Technologies Market, $Billion, 2023-2034
Figure 43: Global Precision Medicine Other Technologies Market (by Region), $Billion, 2023-2034
Figure 44: Role of Biomarkers in Pharmacogenomics
Figure 45: Role of FDA In Pharmacogenomics
Figure 46: Global Precision Medicine Market (by Applied Science) (by Pharmacogenomics), $Billion, 2023-2034
Figure 47: Global Precision Medicine Pharmacogenomics Market (by Pharmacogenomics Services), $Billion, 2023-2034
Figure 48: Global Precision Medicine Pharmacogenomics Market (by End User), $Billion, 2023-2034
Figure 49: Global Precision Medicine Pharmacogenomics Market (by Region), $Billion, 2023-2034
Figure 50: Global Precision Medicine Market (by Applied Science) (by Others), $Billion, 2023-2034
Figure 51: Precision Medicine: Diagnostics
Figure 52: Global Precision Medicine Market (by Precision Diagnostic)
Figure 53: Global Precision Medicine Market (by Precision Diagnostics), $Billion, 2023-2034
Figure 54: Global Precision Medicine Market (by Precision Diagnostics) (by Type), $Billion, 2023-2034
Figure 55: General Workflow of a Molecular Diagnostic Assay
Figure 56: Global Precision Medicine Market (by Molecular Diagnostics)
Figure 57: Global Precision Medicine Market (by Precision Diagnostics) (by Molecular Diagnostics) $Billion, 2023-2034
Figure 58: Global Precision Medicine Market (by Molecular Diagnostics)(by Type), $Billion, 2023-2034
Figure 59: Benefits and Risks Associated with NIPT
Figure 60: Global Precision Medicine NIPT Market, $Billion, 2023-2034
Figure 61: Global Precision Medicine NIPT Market (by Platform)$Billion, 2023-2034
Figure 62: Global Precision Medicine NIPT Market (by Region), $Billion, 2023-2034
Figure 63: Drug and Companion Diagnostics Development Process
Figure 64: Benefits and Risks Associated with Companion Diagnostics
Figure 65: Global Precision Medicine Companion Diagnostics Market, $Billion, 2023-2034
Figure 66: Global Precision Medicine Companion Diagnostics Market (by Technology), $Billion, 2023-2034
Figure 67: Global Precision Medicine Companion Diagnostics Market (by Indication), $Billion, 2023-2034
Figure 68: Global Precision Medicine Companion Diagnostics Market (by Region), $Billion, 2023-2034
Figure 69: Clinical Applications of Liquid Biopsy
Figure 70: Global Precision Medicine Liquid Biopsy Market, $Billion, 2023-2034
Figure 71: Global Precision Medicine Liquid Biopsy Market (by Indication), $Billion, 2023-2034
Figure 72: Global Precision Medicine Liquid Biopsy Market (by Region), $Billion, 2023-2034
Figure 73: Global Precision Medicine Other Molecular Diagnostics Market, $Billion, 2023-2034
Figure 74: Global Precision Medicine Other Molecular Diagnostics Market (by Type), $Billion, 2023-2034
Figure 75: Global Precision Medicine Other Molecular Diagnostics Market (by Region), $Billion, 2023-2034
Figure 76: Global Precision Medicine Market (by Precision Diagnostics) (by Medical Imaging) $Billion, 2023-2034
Figure 77: Global Precision Medicine Market (by Precision Diagnostics) (by Medical Imaging) (by Type), $Billion, 2023-2034
Figure 78: Global Precision Medicine Imaging Analytics Market, $Billion, 2023-2034
Figure 79: Global Precision Medicine CADx Market, Billion,2023-2034
Figure 80: Global Precision Medicine Market (by Precision Diagnostics) (by Medical Imaging) (by Region), $Billion, 2023-2034
Figure 81: Global Precision Medicine Digital Health and Information Technology Market, $Billion, 2023-2034
Figure 82: Global Precision Medicine Digital Health and Information Technology Market (by Type), $Billion, 2023-2034
Figure 83: Global Precision Medicine Market (by Digital Health and Information Technology) (by CDSS) $Billion, 2023-2034
Figure 84: Big Data Attributes
Figure 85: Global Precision Medicine Market (by Digital Health and Information Technology) (by Big Data Analytics) $Billion, 2023-2034
Figure 86: Big Data Analytics: Key Benefits
Figure 87: Global Precision Medicine Market (by Digital Health and Information Technology) (by IT Infrastructure) $Billion, 2023-2034
Figure 88: Global Precision Medicine Market (by Digital Health and Information Technology) (by IT Infrastructure) (by Type) $Billion, 2023-2034
Figure 89: Global Precision Medicine Market (by Digital Health and Information Technology) (by Genomics Informatics) $Billion, 2023-2034
Figure 90: Global Precision Medicine Market (by Digital Health and Information Technology) (by Genomics Informatics) (by Product Type) $Billion, 2023-2034
Figure 91: Global Precision Medicine Market (by Digital Health and Information Technology) (by In-silico Informatics) $Billion, 2023-2034
Figure 92: Global Precision Medicine Market (by Digital Health and Information Technology) (by Mobile Health) $Billion, 2023-2034
Figure 93: Global Precision Medicine Market (by Digital Health and Information Technology Market) (by End User), $Billion, 2023-2034
Figure 94: Global Precision Medicine Market (by Digital Health and Information Technology (by Region), $Billion, 2023-2034
Figure 95: Global Precision Medicine Market (by Precision Therapeutics) $Billion, 2023-2034
Figure 96: Global Precision Medicine Market (by Precision Therapeutics) $Billion, 2023-2034
Figure 97: Global Precision Medicine Market (by Precision Therapeutics) (by Clinical Trials) $Billion, 2023-2034
Figure 98: Global Precision Medicine Market (by Precision Therapeutics) (by Clinical Trials) (by Region), $Billion, 2023-2034
Figure 99: Types of Cell Therapy
Figure 100: Global Precision Medicine Market (by Precision Therapeutics) (by Cell Therapy), $Billion, 2023-2034
Figure 101: Global Precision Medicine Market (by Precision Therapeutics) (by Cell Therapy) (by Region), $Billion, 2023-2034
Figure 102: Global Precision Medicine Market (by Precision Therapeutics) (by Drug Discovery and Research) $Billion, 2023-2034
Figure 103: Global Precision Medicine Market (by Precision Therapeutics) (by Drug Discovery and Research) (by Region), $Billion, 2023-2034
Figure 104: Types of Gene Therapy
Figure 105: Types of Gene Therapy
Figure 106: Global Precision Medicine Market (by Precision Therapeutics) (by Gene Therapy), $Billion, 2023-2034
Figure 107: Global Precision Medicine Market (by Precision Therapeutics) (by Gene Therapy) (by Region), $Billion, 2023-2034
Figure 108: Types of Cancer
Figure 109: Global Precision Medicine Market (by Oncology), $Billion, 2023-2034,
Figure 110: Global Precision Medicine Market (by Infectious Diseases) $Billion, 2023-2034
Figure 111: Number of Deaths by Top 4 Infectious Diseases, 2022
Figure 112: Global Precision Medicine Market (by Neurology), $Billion, 2023-2034
Figure 113: Global Precision Medicine Market (by Cardiovascular Disease), $Billion, 2023-2034
Figure 114: Global Precision Medicine Market (by Lifestyle and Endocrinology), $Billion, 2023-2034
Figure 115: Global Precision Medicine Market (by Gastroenterology) $Billion, 2023-2034
Figure 116: Global Precision Medicine Market (by Other Application) Market, $Billion, 2023-2034
Figure 117: North America Precision Medicine Market, $Billion, 2023-2034
Figure 118: U.S. Precision Medicine Market, $Billion, 2023-2034
Figure 119: Canada Precision Medicine Market, $Billion, 2023-2034
Figure 120: Europe Precision Medicine Market, $Billion, 2023-2034
Figure 121: Germany Precision Medicine Market, $Billion, 2023-2034
Figure 122: France Precision Medicine Market, $Billion, 2023-2034
Figure 123: Italy Precision Medicine Market, $Billion, 2023-2034
Figure 124: U.K. Precision Medicine Market, $Billion, 2023-2034
Figure 125: Spain Precision Medicine Market, $Billion, 2023-2034
Figure 126: Rest of Europe Precision Medicine Market, $Billion, 2023-2034
Figure 127: Asia-Pacific Precision Medicine Market, $ Billion, 2023-2034
Figure 128: Japan Precision Medicine Market, $Billion, 2023-2034
Figure 129: China Precision Medicine Market, $Billion, 2023-2034
Figure 130: India Precision Medicine Market, $Billion, 2023-2034
Figure 131: Australia Precision Medicine Market, $Billion, 2023-2034
Figure 132: South Korea Precision Medicine Market, $Billion, 2023-2034
Figure 133: Rest-of-APAC Precision Medicine Market, $Billion, 2023-2034
Figure 134: Latin America Precision Medicine Market $Billion,2023-2034
Figure 135: Brazil Precision Medicine Market, $Billion, 2023-2034
Figure 136: Mexico Precision Medicine Market, $Billion, 2023-2034
Figure 137: Rest-of-Latin America Precision Medicine Market, $Billion, 2023-2034
Figure 138: Middle East and Africa Precision Medicine Market, $Billion, 2023-2034
Figure 139: K.S.A Precision Medicine Market, $Billion, 2023-2034
Figure 140: South Africa Precision Medicine Market, $Billion, 2023-2034
Figure 141: Rest-of-MEA Precision Medicine Market, $Billion 2023-2034
Figure 142: Synergistic Activities, by Company (January 2020- January 2025)
Figure 143: Synergistic Activities, by Type (January 2020- January 2025)
Figure 144: Data Triangulation
Figure 145: Top-Down and Bottom-Up Approach

List of Tables
Table 1: Market Snapshot
Table 2: Application
Table 3: Pipeline Analysis (by Company)
Table 4: Pipeline Analysis (by Product)
Table 5: Precision Medicine Drugs Pipeline Analysis
Table 6: Ecosystem Summary
Table 7: List of Few FDA-Approved Pharmacogenomics Biomarkers in Drug Labeling
Table 8: Key Approved Therapeutics with FDA-Mandated Companion Diagnostics Tests
Table 9: List of FDA-Approved Companion Diagnostics
Table 10: Commercially Available Primary and Secondary Analysis Tools Providers
Table 11: Product Summary
Table 12: Cancer Precision Medicine Drugs and Indications
Table 13: Infectious Diseases Precision Medicine Drugs and Indications
Table 14: Neurology Precision Medicine Drugs and Indications
Table 15: Cardiovascular Precision Medicine Drugs/Tests/ and Indications
Table 16: Endocrinology Precision Medicine Drugs and Indications
Table 17: Gastroenterology Precision Medicine Drugs and Indications
Table 18: Precision Drugs for Other Applications
Table 19: Global Precision Medicine Market (by Region), $Million, 2023-2034
Table 20: North America Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 21: U.S. Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 22: Canada Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 23: Europe Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 24: Germany Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 25: France Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 26: Italy Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 27: Funding Scenario in Universities
Table 28: U.K. Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 29: Spain. Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 30: Rest-of-Europe Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 31: Asia-Pacific Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 32: Japan Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 33: China Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 34: India Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 35: Australia Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 36: South Korea. Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 37: Rest-of-APAC Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 38: Latin America Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 39: Brazil Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 40: Mexico Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 41: Rest-of-Latin America Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 42: Middle East and Africa Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 43: K.S.A Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 44: South Africa Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 45: Rest-of-MEA Precision Medicine Market (by Ecosystem